<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nearly 50 % of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) patients develop <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> with liver resection being the only option to cure patients </plain></SENT>
<SENT sid="1" pm="."><plain>Residual micrometastases or circulating <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells are considered a cause of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> relapse </plain></SENT>
<SENT sid="2" pm="."><plain>This work investigates the influence of partial hepatectomy (PH) on the growth and molecular composition of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> in a syngeneic rat model </plain></SENT>
<SENT sid="3" pm="."><plain>One million CC531 <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> cells were implanted via the portal vein in WAG/Rij rats followed by a 30 % PH a day later </plain></SENT>
<SENT sid="4" pm="."><plain>Control groups either received <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells followed by a sham-operation or were injected with a buffer solution followed by PH </plain></SENT>
<SENT sid="5" pm="."><plain>Animals were examined with magnetic resonance imaging (MRI) and liver tissues were processed for immunolabeling and PCR analysis </plain></SENT>
<SENT sid="6" pm="."><plain>One-third PH was associated with an almost threefold increase in relative <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> mass (MRI volumetry: 2.8-fold and transcript levels of CD44: 2.3-fold) </plain></SENT>
<SENT sid="7" pm="."><plain>Expression of molecular markers for invasiveness and <z:hpo ids='HP_0000718'>aggressiveness</z:hpo> (CD49f, CXCR4, Axin2 and c-met) was increased following PH, however with no significant differences when referring to the relative expression levels (relating to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> mass) </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">Liver metastases</z:e> demonstrated a significantly higher proliferation rate (Ki67) 2 weeks following PH and cell divisions also increased in the surrounding liver tissue </plain></SENT>
<SENT sid="9" pm="."><plain>Following PH, the stimulated growth of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> clearly exceeded the compensation in liver volume with long-lasting proliferative effects </plain></SENT>
<SENT sid="10" pm="."><plain>However, the distinct <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> composition was not influenced by <z:e sem="disease" ids="C1318485" disease_type="Disease or Syndrome" abbrv="">liver regeneration</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Future investigations should focus on the inhibition of cell cycle (i.e. systemic therapy strategies, irradiation) to hinder <z:e sem="disease" ids="C1318485" disease_type="Disease or Syndrome" abbrv="">liver regeneration</z:e> and therefore restrain <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> </plain></SENT>
</text></document>